Kamyar Hadian

@k-hadian.bsky.social

Deputy Director, Research Unit Signaling & Translation @ Helmholtz Munich Ferroptosis • Cell Death • Metabolism Ubiquitin • Cell Signaling Chemical Biology • Drug Discovery

Happy to share the final version of the study where we describe a central role for vitaminB2 in regulating membrane redox state - some new cool experiments were added since the preprint was posted - pls check this out thttps://www.nature.com/articles/s41556-025-01856-x

Riboflavin metabolism shapes FSP1-driven ferroptosis resistance - Nature Cell Biology

After performing a focused CRISPR–Cas9 screen, Skafar et al. identify riboflavin (vitamin B2) as a regulator of FSP1 stability that modulates phospholipid peroxidation and ferroptosis sensitivity in c...

nature.com

I’m excited to lead this new journal that will focus on how cells interact with their environment. We are assembling a top tier editorial board, key partnerships, and looking to be the primary forum for the rapidly growing field of spatial biology.

EXO - Beyond the Cell@exo-beyondthecell.bsky.social · 10mo ago

🚀 EXO – Beyond the Cell is Here! Science Exploration Press proudly launches the journal of EXO – Beyond the Cell. www.sciexplor.com/exo Prof. Brent R. Stockwell(Columbia University) @brentstockwell.bsky.social, a member of the U.S. National Academy of Medicine, serves as founding Editor-in-Chief.

Hot off the presses! Was an honor to team up with Scott Dixon @stanforduniversity.bsky.social on this Nature Cancer review. We reflect on hurdles that have slowed translation of ferroptosis-directed therapies and share ideas on what it will take to bring these therapies to the clinic. rdcu.be/eBbqV

Prospects for ferroptosis therapies in cancer

Nature Cancer - Ubellacker and Dixon summarize the latest discoveries on ferroptosis in cancer, covering the molecular and cellular pathways underlying sensitivity and resistance to this type of...

rdcu.be

Harvard Molecular Metabolism@met-hsph.bsky.social · 12mo ago

Ferroptosis-targeting therapies in cancer have yet to make it to the clinic. New review published today in Nature Cancer by @ubellackerlab.bsky.social and Scott Dixon of Stanford share hurdles and ideas for future strategies to bring these therapies closer to the clinic. Check it out rdcu.be/eBbqV